Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

LeukoSite, Warner-Lambert collaborate on integrin antagonist research

Jan. 19, 1999

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

Jan. 19, 1999

Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products

Jan. 18, 1999

Tenth HuMAb-Mouse licensing agreement for Medarex: Immunex granted broad rights

Jan. 18, 1999

Milestone reached by Cadus in drug discovery collaboration with SmithKline Beecham

Jan. 18, 1999

Rigel and Janssen enter drug discovery collaboration

Jan. 15, 1999

Isis and Abbott establish antisense target validation partnership

Jan. 15, 1999

VP22 increases the efficacy of suicide gene therapy in vivo

Jan. 15, 1999

Telik and Cor Therapeutics enter drug screening and licensing agreement

Jan. 14, 1999

Medarex receives milestone payment from Centocor related to HuMAb-Mouse technology

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...